Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041855
Filing Date
2019-11-07
Accepted
2019-11-07 17:01:42
Documents
67
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q urov-10q_20190930.htm 10-Q 2330045
2 EX-31.1 urov-ex311_6.htm EX-31.1 17908
3 EX-31.2 urov-ex312_7.htm EX-31.2 17918
4 EX-32.1 urov-ex321_9.htm EX-32.1 9684
5 EX-32.2 urov-ex322_10.htm EX-32.2 9675
6 GRAPHIC gbsapxrvcjcz000003.jpg GRAPHIC 11999
7 GRAPHIC gbsapxrvcjcz000004.jpg GRAPHIC 12824
8 GRAPHIC gbsapxrvcjcz000001.jpg GRAPHIC 22064
9 GRAPHIC gbsapxrvcjcz000002.jpg GRAPHIC 21687
  Complete submission text file 0001564590-19-041855.txt   6490788

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT urov-20190930.xml EX-101.INS 1023377
11 XBRL TAXONOMY EXTENSION SCHEMA urov-20190930.xsd EX-101.SCH 48867
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urov-20190930_cal.xml EX-101.CAL 49884
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urov-20190930_def.xml EX-101.DEF 176454
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE urov-20190930_lab.xml EX-101.LAB 400510
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urov-20190930_pre.xml EX-101.PRE 315552
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38667 | Film No.: 191201188
SIC: 2834 Pharmaceutical Preparations